 |
PDBsum entry 1m3e
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Structure of the mammalian CoA transferase from pig heart.
|
 |
|
Authors
|
 |
K.S.Bateman,
E.R.Brownie,
W.T.Wolodko,
M.E.Fraser.
|
 |
|
Ref.
|
 |
Biochemistry, 2002,
41,
14455-14462.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Ketoacidosis affects patients who are deficient in the enzyme activity of
succinyl-CoA:3-ketoacid CoA transferase (SCOT), since SCOT catalyses the
activation of acetoacetate in the metabolism of ketone bodies. Thus far,
structure/function analysis of the mammalian enzyme has been predicted based on
the three-dimensional structure of a CoA transferase determined from an
anaerobic bacterium that utilizes its enzyme for glutamate fermentation. To
better interpret clinical data, we have determined the structure of a mammalian
CoA transferase from pig heart by X-ray crystallography to 2.5 A resolution.
Instrumental to the structure determination were selenomethionine substitution
and the use of argon during purification and crystallization. Although pig heart
SCOT adopts an alpha/beta protein fold, resembling the overall fold of the
bacterial CoA transferase, several loops near the active site of pig heart SCOT
follow different paths than the corresponding loops in the bacterial enzyme,
accounting for differences in substrate specificities. Two missense mutations
found associated with SCOT of ketoacidosis patients were mapped to a location in
the structure that might disrupt the stabilization of the amino-terminal strand
and thereby interfere with the proper folding of the protein into a functional
enzyme.
|
 |
|
|
|
|
 |